Your browser doesn't support javascript.
loading
Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality.
Xie, Qian-Kun; He, Wen-Zhuo; Hu, Wan-Ming; Yang, Lin; Jiang, Chang; Kong, Peng-Fei; Yang, Yuan-Zhong; Yang, Qiong; Zhang, Hui-Zhong; Zhang, Bei; Xia, Liang-Ping.
Afiliação
  • Xie QK; VIP Region, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • He WZ; VIP Region, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Hu WM; Department of Pathology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, SunYat-sen University Cancer Center, Guangzhou, China.
  • Yang L; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Jiang C; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Kong PF; VIP Region, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yang YZ; VIP Region, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yang Q; VIP Region, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhang HZ; Department of Pathology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, SunYat-sen University Cancer Center, Guangzhou, China.
  • Zhang B; VIP Region, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Xia LP; Department of Oncology, Sun Yat-sen Memorial Hospital, Guangzhou, China.
Cancer Manag Res ; 10: 1365-1375, 2018.
Article em En | MEDLINE | ID: mdl-29881307
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Manag Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Manag Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China